Q1 2022 Holdings
Filed 2022-05-16 | 86 holdings | $1.3B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Community Health SYS Inc New(CYH)A | COM | 203668108 | $84.6M | 7,126,711 | 6.5% |
| Biohaven Pharmactl Hldg Co L(BHVN)A | COM | G11196105 | $76.4M | 644,666 | 5.9% |
| Glaxosmithkline PLCCallA | SPONSORED ADR | 37733W105 | $67.7M | 1,553,700 | 5.2% |
| Invesco QQQ TR(QQQ)PutA | UNIT SER 1 | 46090E103 | $65.3M | 180,000 | 5.0% |
| Horizon Therapeutics PUB LA | SHS | G46188101 | $64.2M | 609,939 | 4.9% |
| Glaxosmithkline PLCA | SPONSORED ADR | 37733W105 | $55.5M | 1,259,162 | 4.3% |
| United Therapeutics Corp del(UTHR)A | COM | 91307C102 | $52.4M | 292,234 | 4.0% |
| Astrazeneca PLC(AZN)A | SPONSORED ADR | 046353108 | $49.4M | 745,263 | 3.8% |
| Ascendis Pharma A/S(ASND)A | SPONSORED ADR | 04351P101 | $49.0M | 417,172 | 3.8% |
| Danaher Corporation(DHR)A | COM | 235851102 | $46.9M | 159,768 | 3.6% |
| Teva Pharmaceutical Inds LTD(TEVA)A | SPONSORED ADS | 881624209 | $38.9M | 4,143,602 | 3.0% |
| Astrazeneca PLC(AZN)CallA | SPONSORED ADR | 046353108 | $38.0M | 572,300 | 2.9% |
| R1 RCM IncA | COM | 749397105 | $36.4M | 1,361,506 | 2.8% |
| Avantor Inc(AVTR)A | COM | 05352A100 | $33.7M | 995,232 | 2.6% |
| Masimo Corp(MASI)A | COM | 574795100 | $30.4M | 208,970 | 2.3% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $29.5M | 8,980,145 | 2.3% |
| Biogen Inc(BIIB)CallA | COM | 09062X103 | $29.5M | 140,000 | 2.3% |
| HCA Healthcare Inc(HCA)A | COM | 40412C101 | $27.9M | 111,440 | 2.1% |
| Envista Holdings Corporation(NVST)A | COM | 29415F104 | $27.7M | 569,351 | 2.1% |
| Amneal Pharmaceuticals Inc(AMRX)A | COM STK CL A | 03168L105 | $22.9M | 5,491,497 | 1.8% |
| Celldex Therapeutics Inc New(CLDX)A | COM NEW | 15117B202 | $21.7M | 636,453 | 1.7% |
| ARK ETF TR(ARKG)A | GENOMIC REV ETF | 00214Q302 | $21.6M | 470,506 | 1.7% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $17.7M | 456,059 | 1.4% |
| Biogen Inc(BIIB)A | COM | 09062X103 | $16.4M | 78,003 | 1.3% |
| Mckesson Corp(MCK)A | COM | 58155Q103 | $16.1M | 52,375 | 1.2% |
| Anthem Inc(ELV)A | COM | 036752103 | $15.9M | 32,451 | 1.2% |
| Dexcom Inc(DXCM)A | COM | 252131107 | $14.5M | 28,404 | 1.1% |
| Guardant Health Inc(GH)A | COM | 40131M109 | $14.1M | 213,203 | 1.1% |
| Iqvia Hldgs Inc(IQV)A | COM | 46266C105 | $13.8M | 59,570 | 1.1% |
| Illumina Inc(ILMN)A | COM | 452327109 | $13.5M | 38,759 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE)A | COM | 98420N105 | $12.5M | 410,021 | 1.0% |
| Icon PLC(ICLR)A | SHS | G4705A100 | $11.4M | 46,816 | 0.9% |
| Centene Corp del(CNC)A | COM | 15135B101 | $10.0M | 119,170 | 0.8% |
| Laboratory Corp Amer HldgsA | COM NEW | 50540R409 | $10.0M | 37,910 | 0.8% |
| Liquidia Corporation(LQDA)A | COM NEW | 53635D202 | $9.9M | 1,377,490 | 0.8% |
| Nanostring Technologies Inc(NSTGEUR)A | COM | 63009R109 | $9.8M | 280,695 | 0.7% |
| Healthequity Inc(HQY)A | COM | 42226A107 | $9.7M | 144,140 | 0.7% |
| Taro Pharmaceutical Inds LTDA | SHS | M8737E108 | $9.5M | 220,286 | 0.7% |
| Qiagen NV(QGEN)A | SHS NEW | N72482123 | $9.4M | 192,699 | 0.7% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $8.6M | 52,871 | 0.7% |
| Ortho Clinical Diagnostics HA | ORD SHS | G6829J107 | $8.3M | 445,059 | 0.6% |
| Argenx SE(ARGX)A | SPONSORED ADR | 04016X101 | $7.3M | 23,142 | 0.6% |
| Repligen Corp(RGEN)A | COM | 759916109 | $6.9M | 36,521 | 0.5% |
| Syneos Health Inc(8IN)A | CL A | 87166B102 | $6.6M | 81,416 | 0.5% |
| Ishares Inc(EWT)PutA | MSCI TAIWAN ETF | 46434G772 | $6.1M | 100,000 | 0.5% |
| Ionis Pharmaceuticals Inc(IONS)A | COM | 462222100 | $5.9M | 158,806 | 0.5% |
| Zentalis Pharmaceuticals Inc(ZNTL)A | COM | 98943L107 | $4.6M | 100,187 | 0.4% |
| Exelixis Inc(EXEL)A | COM | 30161Q104 | $4.6M | 203,156 | 0.4% |
| Irhythm Technologies Inc(IRTC)A | COM | 450056106 | $4.3M | 27,047 | 0.3% |
| 908 Devices Inc(MASS)A | COM | 65443P102 | $4.1M | 217,149 | 0.3% |